Company Valuation: Neuronetics, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 117.6 187 83.91 89.6 94.51 112.7 - -
Change - 59.02% -55.13% 6.79% 5.48% 19.28% - -
Enterprise Value (EV) 117.6 187 83.91 89.6 94.51 112.7 112.7 112.7
Change - 59.02% -55.13% 6.79% 5.48% 19.28% 0% 0%
P/E -3.66x -4.98x -2.76x -1.18x -2.34x -3.5x -4.81x -5.23x
PBR - - - - - - - -
PEG - -0.4x 0.1x -0x 0x 0.2x 0.2x 0.66x
Capitalization / Revenue 2.13x 2.87x 1.18x 1.2x 0.63x 0.7x 0.63x 0.57x
EV / Revenue 0x 0x 0x 0x 0x 0.7x 0.63x 0.57x
EV / EBITDA -0x -0x -0x -0x -0x -8.54x -28.2x 66.3x
EV / EBIT -0x -0x -0x -0x -0x -4.51x -6.4x -8.23x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -1.22 -1.38 -1.05 -1.37 -0.59 -0.4633 -0.3367 -0.31
Distribution rate - - - - - - - -
Net sales 1 55.31 65.21 71.35 74.5 149.2 161.1 177.9 197.8
EBITDA 1 -26.11 -24.72 -28.55 -21.27 -21.12 -13.2 -4 1.7
EBIT 1 -27.56 -35.11 -30.55 -34.04 -31.44 -25.01 -17.61 -13.7
Net income 1 -31.19 -37.16 -30.19 -43.2 -39.14 -32.87 -25.74 -22.5
Net Debt - - - - - - - -
Reference price 2 4.460 6.870 2.900 1.610 1.380 1.620 1.620 1.620
Nbr of stocks (in thousands) 26,368 27,221 28,933 55,652 68,486 69,588 - -
Announcement Date 08/03/22 07/03/23 05/03/24 04/03/25 17/03/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-3.5x - - - 113M
26.66x4.79x18.41x0.35% 198B
32.98x6.37x20.04x0.7% 144B
37.55x9.83x21.78x-.--% 122B
16.19x3.34x10.74x-.--% 65.44B
30.57x6.83x21.8x-.--% 49.36B
18.62x2.14x11.1x2.82% 44.75B
25.56x5.09x17.4x0.78% 37.13B
44.72x6.25x19.21x-.--% 36.23B
14.18x1.58x8.81x0.23% 28.69B
Average 24.35x 5.14x 16.59x 0.54% 72.62B
Weighted average by Cap. 28.92x 5.76x 18.00x 0.46%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. STIM Stock
  4. Valuation Neuronetics, Inc.